Eibsee Meeting

Breadcrumb Navigation



QuanterixQuanterix was founded in 2007 and develops ground-breaking tools in high definition diagnostics. The company has developed an ultra-sensitive platform capable of measuring individual proteins at concentrations 1000 times lower than the best immunoassays available today.

The Single Molecule Array (SimoaTM) technology at the heart of the platform enables the detection and quantification of biomarkers previously difficult or impossible to measure, opening up new applications to address significant commercial unmet needs in life science research, in-vitro diagnostic, companion diagnostic, blood screening, and more.

Responsible for content: Quanterix